These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 2188379

  • 1. Bezafibrate and simvastatin (MK-733) in the treatment of primary hypercholesterolaemia.
    Smith DH, Neutel JM, Jankelow D, Myburgh DP.
    S Afr Med J; 1990 May 19; 77(10):500-3. PubMed ID: 2188379
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Comparison between simvastatin and bezafibrate in effect on plasma lipoproteins and apolipoproteins in primary hypercholesterolaemia.
    Schulzeck P, Bojanovski M, Jochim A, Canzler H, Bojanovski D.
    Lancet; 1988 Mar 19; 1(8586):611-3. PubMed ID: 2894548
    [Abstract] [Full Text] [Related]

  • 4. Low-dose effect of simvastatin (MK-733) on serum lipids, lipoproteins, and apolipoproteins in patients with hypercholesterolemia.
    Saku K, Sasaki J, Arakawa K.
    Clin Ther; 1989 Mar 19; 11(2):247-57. PubMed ID: 2736571
    [Abstract] [Full Text] [Related]

  • 5. Comparison of simvastatin and cholestyramine in the treatment of primary hypercholesterolaemia.
    O'Brien RC, Simons LA, Clifton P, Cooper ME, Jennings GL, Jerums G, Nestel PJ, Sullivan D.
    Med J Aust; 1990 May 07; 152(9):480-3. PubMed ID: 2199801
    [Abstract] [Full Text] [Related]

  • 6. [Comparison about the efficacy and tolerability between simvastatin and bezafibrate in the treatment of hypercholesterolemia].
    Bruckert E, Truffert J, De Gennes JL.
    Ann Med Interne (Paris); 1991 May 07; 142(7):505-10. PubMed ID: 1789528
    [Abstract] [Full Text] [Related]

  • 7. Treatment of primary hypercholesterolaemia with simvastatin. New Zealand multicentre evaluation.
    Lintott CJ, Scott RS, Sharpe DN, Nye ER, Charleson H, French JK, White HD, Reuben S, Maling TJ, Lewis GR.
    Med J Aust; 1991 Oct 07; 155(7):433-6. PubMed ID: 1921811
    [Abstract] [Full Text] [Related]

  • 8. Simvastatin therapy for hypercholesterolaemia in patients with coronary heart disease.
    French JK, White HD, Greaves SC.
    N Z Med J; 1990 Feb 14; 103(883):41-3. PubMed ID: 2304688
    [Abstract] [Full Text] [Related]

  • 9. Begin with the real-world patients of non-goal-achieved hypercholesterolemia in taiwan through the ezetimibe/simvastatin tablet - The BRAVO Study.
    Huang JC, Lee TY, Liou MJ, Lin CM, Pei D, Chen ZC, Liu RT, Kwok CF.
    Curr Med Res Opin; 2011 Aug 14; 27(8):1645-51. PubMed ID: 21699369
    [Abstract] [Full Text] [Related]

  • 10. Effects of bezafibrate and of 2 HMG-CoA reductase inhibitors on lipoprotein (a) level in hypercholesterolemic patients.
    Branchi A, Rovellini A, Fiorenza AM, Sommariva D.
    Int J Clin Pharmacol Ther; 1995 Jun 14; 33(6):345-50. PubMed ID: 7582386
    [Abstract] [Full Text] [Related]

  • 11. [Treatment of hypercholesterolemic patients of different age with simvastatin: 1-year study].
    Pernigotti L, Bo M, Poli L, Zanocchi M, Fiandra U, Pedrazzini V, Fabris F.
    Recenti Prog Med; 1991 Mar 14; 82(3):155-62. PubMed ID: 2047557
    [Abstract] [Full Text] [Related]

  • 12. Ezetimibe/simvastatin 10/20 mg versus simvastatin 40 mg in coronary heart disease patients.
    Averna M, Zaninelli A, Le Grazie C, Gensini GF.
    J Clin Lipidol; 2010 Mar 14; 4(4):272-8. PubMed ID: 21122660
    [Abstract] [Full Text] [Related]

  • 13. Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial.
    Jones PH, Hunninghake DB, Ferdinand KC, Stein EA, Gold A, Caplan RJ, Blasetto JW, Statin Therapies for Elevated Lipid Levels Compared Across Doses to Rosuvastatin Study Group.
    Clin Ther; 2004 Sep 14; 26(9):1388-99. PubMed ID: 15531001
    [Abstract] [Full Text] [Related]

  • 14. [Simvastatin (MK-733), a new HMG-CoA reductase inhibitor, in the treatment of hypercholesterolemia in elderly patients with atherosclerosis].
    Giannini SD, de Góes JM, Dereviack BE, Machado C, Forti N, Diament J.
    Arq Bras Cardiol; 1990 Jun 14; 54(6):407-14. PubMed ID: 2288531
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Treatment of hypercholesterolemia with the HMG CoA reductase inhibitor, simvastatin.
    Berger GM, Marais AD, Seftel HC, Baker SG, Mendelsohn D, Welsh NH, Joffe BI.
    Cardiovasc Drugs Ther; 1989 Apr 14; 3(2):219-27. PubMed ID: 2487533
    [Abstract] [Full Text] [Related]

  • 19. [Effects of simvastatin on plasma levels of lipids, lipoproteins and apolipoproteins in primary hypercholesterolemia].
    Caruzzo C, Uslenghi E, Varbella F, Caruzzo E, Marcolongo M, Brusca A.
    Minerva Cardioangiol; 1989 Dec 14; 37(12):509-15. PubMed ID: 2695857
    [Abstract] [Full Text] [Related]

  • 20. [Simvastatin in the treatment of hypercholesterolemia in the aged. An epidemiological and clinical study].
    Tamburrini LR.
    Minerva Med; 1992 Jun 14; 83(6):347-53. PubMed ID: 1630695
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.